Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Savara (SVRA) posted Net Equity Issued and Repurchased of $194,000 for Q2 2026, up 198.5% from $65,000 a year earlier and up 331.1% from the prior quarter.

Analysis

Savara (SVRA) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Savara was $140.59 million, up 49.1% year-over-year; for FY2025, it was $140.58 million, up 49.3% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 101.8% (FY2020 to FY2025).
  • In prior years, Savara's Net Equity Issued and Repurchased was $94.15 million in FY2024, $283,000 in FY2023, $2,000 in FY2022 (-100.0%) and $122.25 million in FY2021.
  • Quarterly Net Equity Issued and Repurchased has run from a low of $10,000 in Q3 2021 to a high of $140.35 million in Q4 2025 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 160.2%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 490.9%; the weakest was Q4 2021, with a decline of 95.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17,000.00
Jun 30, 2026 194,000.00
Mar 31, 2026 45,000.00
Dec 31, 2025 140.35 Mn
Jun 30, 2025 65,000.00
Mar 31, 2025 165,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 94.04 Mn
Jun 30, 2024 11,000.00
Mar 31, 2024 51,000.00
Dec 31, 2023 89,000.00
Sep 30, 2023 63,000.00
Jun 30, 2023 104,000.00
Mar 31, 2023 27,000.00
Dec 31, 2021 84,000.00
Sep 30, 2021 10,000.00
Jun 30, 2021 324,000.00
Mar 31, 2021 121.83 Mn
Dec 31, 2020 1.83 Mn
Jun 30, 2020 2.33 Mn
API Access

Savara Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SVRA&period=max&api_key=YOUR_API_KEY